The California Consumer Privacy Act of 2018 (CCPA) adds another set of privacy requirements for health and life sciences companies. Managing the interaction of these new requirements with existing obligations under the Health Insurance Portability and Accountability Act of 1996 (HIPAA), California’s Confidentiality of Medical Information Act (CMIA), and other health privacy laws will continue to be an area of focus in the health privacy community for years to come. In the latest installment of the CCPA blog series, we describe these issues and outline four important steps health and life sciences companies may consider to assess the CCPA’s operational impact.
We have heard the California Consumer Privacy Act of 2018 (CCPA) called many things since its enactment on June 28, 2018. Our experience to date has confirmed the compliance challenge ahead for organizations that engage with the residents of the world’s fifth-largest economy. We will explore the ramifications for businesses of this seminal legislation in this multi-part series, “The Challenge Ahead” authored by members of Hogan Lovells’ CCPA team. In this first installment, we describe recent activity to enact so-called “technical” amendments to the CCPA.
India’s Committee of Experts has submitted a draft Data Protection Bill for review by the Ministry of Electronics and Information Technology. The Bill represents an important milestone for India, which has yet to enact comprehensive, principles-based data protection regulation, lagging a trend set in recent years by Singapore, the Philippines and others in the region playing catch up to Hong Kong and Japan, which have both had such regulation in place for years now.
On July 24, members of the Hogan Lovells global privacy team presented a webinar on the new California Consumer Privacy Act, a ground-breaking new data privacy law that some are calling the United States’ answer to the European Union’s General Data Protection Regulation. In this post, we provide links to the recorded webinar and slide deck.
On June 28, 2018, California’s governor signed Assembly Bill 375, a ground-breaking new data privacy law that some are calling the United States’ answer to the European Union’s General Data Protection Regulation. Particularly in light of California’s status as the world’s 5th largest economy, many are wondering how the new California Consumer Privacy Act will affect them. Please join members of the Hogan Lovells global privacy team for a live webinar on July 24 to learn what you should be focusing on now.
California continues to be a first mover in privacy in the United States, enacting the US’s toughest and most comprehensive privacy legislation on Thursday, June 28, 2018. Unlike existing state and federal privacy legislation that has generally focused on specific sectors or privacy issues, the California Consumer Privacy Act of 2018 (AB 375), applies broadly to businesses that collect personal information about California consumers and aims to create significant new consumer privacy rights. In doing so, it creates significant new obligations for businesses.
On June 22, California lawmakers announced Assembly Bill 375, a broad-based consumer privacy bill that is intended to serve as an alternative to the California Consumer Privacy Act, a far-reaching consumer privacy initiative that is on track to be on the California ballot this November. The chief sponsor of the CCPA, Alastair Mactaggart, has stated that he will withdraw the initiative from the ballot if AB 375 is passed this week.
Recently, the Russian Data Privacy Authority, Roskomnadzor, organized an Open Doors Day in honor of the International Data Privacy Day. During the occasion, Roskomnadzor officers presented on the authority’s 2017 enforcement activities. They followed this presentation with an open question and answer period, during which they responded to numerous questions raised by attendees. This post summarizes the key takeaways.